RxSIGHT, INC. (RXST) stock plummeted 6.06% on Wednesday, likely due to a series of analyst rating and price target adjustments.
BTIG lowered its price target on RXST from $58 to $44, although it maintained a Buy rating. The firm's decision to lower the price target could have contributed to the stock's decline, as it reflects a more conservative valuation outlook.
Meanwhile, Stifel Nicolaus maintained a Hold rating on RXST and set a price target of $33, while Needham reiterated its $43 price target on the stock. These neutral-to-negative analyst actions may have weighed on investor sentiment, leading to the selloff in RXST shares.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.